Skip to main content
Erschienen in:

06.02.2021 | Others

Hepatocellular Carcinoma in India

verfasst von: Hitesh J. Chavda

Erschienen in: Indian Journal of Surgery | Sonderheft 4/2021

Einloggen, um Zugang zu erhalten

Abstract

Hepatocellular carcinoma (HCC) is the fifth most common cancer in the world. The incidence of HCC is rising in India and is one of the leading GI cancers. The prevalence of HCC in India varies from 0.2 to 1.6%. The age adjusted incidence rate of HCC in India for men ranges from 0.7 to 7.5 per 100,000 populations, and for women 0.2 to 2.2 per 100,000 populations. The male to female ratio for HCC in India is 4:1. The incidence of HCC in cirrhotic in India is 1.6% per year. The age standardized mortality rate for HCC in India for men is 6.8/100,000 and for women is 5.1/100,000. HBV is the main etiological factor associated with HCC in India. Due to high prevalence of HBV infection in India, the surveillance is poor and there has been no comprehensively analyzed data for HCC. Despite recent advances in the treatment of HCC, many patients cannot be cured due to the advanced stage of HCC at the time of diagnosis in India. Optimal application of multidisciplinary team approach and active involvement in clinical studies with new agents in HCC patients are critically important.

Literatur
  1. Kew MC (2010) Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma. Pathol Biol (Paris) 58:273–277View Article
  2. Annual Report 1987 (1990) National Cancer Registry Programme. New Delhi, Indian Council of Medical Research
  3. Jayant K, Rao RS, Nene BM, Dale PS (1994) Rural Cancer Registry at Barshi- Report 1988-92. Barshi, Rural Cancer Registry
  4. Acharya SK (2014) Epidemiology of hepatocellular carcinoma in India. J Clin Exp Hepatol 4(Suppl 3):S27–S33View Article
  5. Dikshit R, Gupta PC, Ramasundarahettige C et al (2012) Million Death Study Collaborators. Cancer mortality in India: a nationally representative survey. Lancet 379(9828):1807–1816. https://​doi.​org/​10.​1016/​S0140-6736(12)60358-4 Erratum in: Lancet. 2012 May 12;379(9828):1790View ArticlePubMed
  6. Paul SB et al (2007) Incidence of hepatocellular carcinoma among Indian patients with cirrhosis of liver: an experience from a tertiary care center in northern India. Indian J Gastroenterol 26(6):274–278PubMed
  7. (2009) World Gastroenterology Organization Global Guideline Hepatocellular Carcinoma (HCC): A Global Perspective
  8. Austin H, Deizell E, Grufferman et al (1986) A case-control study of hepatocellular carcinoma and the hepatitis B virus, cigarette smoking and alcohol consumption. Cancer Res 46:962–966PubMed
  9. Groopman JD, Kensler TW, Wild CP (2008) Protective interventions to prevent aflatoxin-induced carcinogenesis in developing countries. Annu Rev Public Health 29:187–203View Article
  10. Regimbeau JM, Colombat M et al (2004) Obesity and diabetes as a risk factor for hepatocellular carcinoma. Liver Transpl 10(2 suppl 1):S69–S73View Article
  11. Wang C, Wang X, Gong G et al (2012) Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: a systematic review and meta-analysis of cohort studies. Int J Cancer 130:1639–1648View Article
  12. Llovet JM, Burroughs A, Bruix J (2003) Hepatocellular carcinoma. Lancet. 362(9399):1907–1917View Article
  13. Kumar A, Acharya SK, Singh SP, Saraswat VA et al (2014) The Indian National Association for Study of the Liver (INASL) Consensus on prevention, diagnosis and management of hepatocellular carcinoma in India: The Puri Recommendations. J Clin Exp Hepatol 4(Suppl 3):S3–S26View Article
  14. White DL, Kanwal F, El-Serag HB (2012) Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review. Clin Gastroenterol Hepatol 10(12):1342–1359View Article
  15. Singal A, Volk ML, Waljee A et al (2009) Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis. Aliment Pharmacol Ther 30(1):37–47View Article
  16. Sheu JC, Sung JL, Chen DS et al (1985) Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications. Gastroenterology. 89(2):259–266View Article
  17. Talbot J-N, Fartoux L, Balogova S et al (2010) Detection of hepatocellular carcinoma with PET/CT: a prospective comparison of 18F-fluorocholine and 18F-FDG in patients with cirrhosis or chronic liver disease. J Nucl Med 51(11):1699–1706View Article
  18. Bruix J, Llovet JM (2002) Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology. 35:519–524View Article
  19. El-Serag HB (2011) Hepatocellular carcinoma. N Engl J Med 365(12):1118–1127View Article
  20. Tan Y, Zhang W, Jiang L, Yang J, Yan L. Efficacy and safety of anatomic resection versus nonanatomic resection in patients with hepatocellular carcinoma: A systemic review and meta-analysis. PLoS One. 2017 26;12(10):e0186930. https://​doi.​org/​10.​1371/​journal.​pone.​0186930.
  21. Zhou Y, Xu D, Wu L, Li B (2011) Meta-analysis of anatomic resection versus nonanatomic resection for hepatocellular carcinoma. Langenbeck's Arch Surg 396(7):1109–1117View Article
  22. Bhandare MS, Patkar S, Shetty N, Polnaya A, Kulkarni S, Dusane RR, Shrikhande SV, Goel M. Liver resection for HCC outside the BCLC criteria. Langenbecks Arch Surg. 2018 403(1):37–44. https://​doi.​org/​10.​1007/​s00423-017-1640-3
  23. Pamecha V et al (2017) Major liver resection for large and locally advanced hepatocellular carcinoma. Indian J Surg 79(4):326–331View Article
  24. Panwar R, Pal S, Dash NR et al (2016 Jul) Hepatic resection for predominantly large size hepatocellular carcinoma: early and long-term results from a tertiary care center in India. Indian J Gastroenterol 35(4):280–286. https://​doi.​org/​10.​1007/​s12664-016-0678-4.​View ArticlePubMed
  25. Mazzaferro V, Regalia E et al (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334(11):693–699View Article
  26. Yao FY, Ferrell L et al (2001) Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology. 33(6):1394–1403View Article
  27. Takayasu K, Arii S, Ikai I et al (2006) Prospective cohort study of trans- arterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology. 131(2):461–469View Article
Metadaten
Titel
Hepatocellular Carcinoma in India
verfasst von
Hitesh J. Chavda
Publikationsdatum
06.02.2021
Verlag
Springer India
Erschienen in
Indian Journal of Surgery / Ausgabe Sonderheft 4/2021
Print ISSN: 0972-2068
Elektronische ISSN: 0973-9793
DOI
https://doi.org/10.1007/s12262-021-02762-w

Neu im Fachgebiet Chirurgie

Ab sofort gelten die neuen Verordnungsausnahmen für Lipidsenker

Freie Fahrt für Lipidsenker? Das nicht, doch mit niedrigerem Schwellenwert fürs Infarktrisiko und neuen Indikationen hat der G-BA die Verordnungs-Handbremse ein gutes Stück weit gelockert.

Appendizitis und Darminfarkt durch Blinddarm-Lipom

Eigentlich sind Lipome recht harmlos. Im Zäkum können sie jedoch erhebliche Komplikationen mit Darminfarkt und Appendizitis verursachen.

Gluteuslappen nach Rektumkarzinom-Op. schützt vor Abszessen

Die Wunddeckung mit einem autologen Rotationslappen nach Entfernung eines Rektumkarzinoms konnte in einer randomisierten Studie gegenüber dem primären Wundverschluss vor allem in einer Hinsicht punkten: Sie führte deutlich seltener zu präsakralen Abszessen.

Webinar

MedTalk Leitlinie KOMPAKT: S3-Leitline zu peripheren Nervenverletzungen

  • Webinar | 10.02.2025 | 13:00

Über den Weg zur finalen Fassung der S3-Leitlinie "Versorgung peripherer Nervenverletzungen" spricht Prof. Dr. Leila Harhaus-Wähner im MedTalk Leitlinie KOMPAKT. In dem kurzen Video geht es darum, was sich im Vergleich zur vorigen Fassung der Leitlinie geändert hat, welche Aspekte für die tägliche Praxis besonders wichtig sind und was jeder gemäß Leitlinie nun anders oder besser machen sollte.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.